LUCD•prnewswire•
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree
Summary
Recognized as the leading company in its size category in program honoring the top workplaces across the diagnostics and precision-medicine sectors NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 20, 2025 by prnewswire